Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.43 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.43 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | CCR1 | P32246 | 2/20 | 0.35 |
| ▸ | CCR5 | P51681 | 2/20 | 0.35 |
| ▸ | CCR8 | P51685 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | METAP1 | P53582 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.35 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11321938 | 0.86 | EHMT2 (0.39) | APOBEC3GEHMT2EHMT1HSD17B10HDAC8 | |
| SCHEMBL11319203 | 0.86 | EHMT2 (0.39) | APOBEC3GEHMT2EHMT1HSD17B10HDAC8 | |
| SCHEMBL11832740 | 0.85 | APOBEC3G (0.35) | APOBEC3GEHMT2EHMT1HSD17B10HDAC8 | |
| SCHEMBL11825510 | 0.85 | KMT2A (0.46) | APOBEC3GEHMT2EHMT1HSD17B10MAPK1 | |
| SCHEMBL10528302 | 0.81 | — | — | |
| SCHEMBL11446563 | 0.81 | — | — | |
| SCHEMBL11819786 | 0.79 | KMT2A (0.40) | APOBEC3GEHMT2EHMT1HSD17B10MAPK1 | |
| SCHEMBL11834418 | 0.78 | HSD17B10 (0.38) | APOBEC3GEHMT2EHMT1HSD17B10MAPK1 | |
| SCHEMBL11819681 | 0.78 | EHMT2 (0.40) | APOBEC3GEHMT2EHMT1HSD17B10HDAC8 | |
| SCHEMBL4135470 | 0.77 | HSD17B10 (0.40) | APOBEC3GEHMT2EHMT1HSD17B10HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751366-A | Dual-mechanism deep fungal infection resistant medicament | 上海友长医药有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119431313-A | Antifungal compound, preparation method and application thereof | 上海交通大学 | 2025-02-14 | — | — | CN | claimed |
| CN-119751366-A | Dual-mechanism deep fungal infection resistant medicament | 上海友长医药有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119431313-A | Antifungal compound, preparation method and application thereof | 上海交通大学 | 2025-02-14 | — | — | CN | disclosed |
| US-12091425-B2 | Compounds that inhibit MCL-1 protein | AMGEN INC. (US) | 2024-09-17 | — | — | US | disclosed |
| US-20240016755-A1 | METHOD FOR RAPIDLY OBTAINING ALBUMIN NANOPARTICLES LOADED WITH MAGNETIC NANOPARTICLES | UNIVERSIDAD TÉCNICA FEDERICO SANTA MARÍA (CL) | 2024-01-18 | — | — | US | disclosed |
| US-20230365790-A1 | VULCANIZED RUBBER COMPOSITION AND TIRE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-11-16 | — | — | US | disclosed |
| US-20230365790-A1 | VULCANIZED RUBBER COMPOSITION AND TIRE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-11-16 | — | — | US | disclosed |
| US-11760864-B2 | Trisulfide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-19 | — | — | US | disclosed |
| US-11760864-B2 | Trisulfide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-19 | — | — | US | disclosed |
| CN-116685354-A | Method for rapidly obtaining albumin nanoparticles loaded with magnetic nanoparticles | 费德里科·圣玛利亚技术大学 | 2023-09-01 | — | — | CN | disclosed |
| US-5079305-A | Improved cure rate, scorch delay and reversion resistance | MONSANTO COMPANY (US) | 1992-01-07 | — | — | US | disclosed |
| EP-0417057-A2 | Heterocyclic thiol-based sulfenimide compounds and rubber compositions containing them | MONSANTO COMPANY (US) | 1991-03-13 | — | — | EP | disclosed |
| EP-0248932-B1 | PROCESS FOR PREPARING POLYAMIDES | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1991-01-09 | — | — | EP | disclosed |
| US-4754016-A | Process for preparing polyamide with organic phosphine/organic disulfide mixture condensing agent | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1988-06-28 | — | — | US | disclosed |
| EP-0051234-B1 | A PROCESS FOR THE PRODUCTION OF A 2-AZETIDINONE DERIVATIVE | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1985-03-13 | — | — | EP | disclosed |
| EP-0051234-A1 | A process for the production of a 2-azetidinone derivative | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1982-05-12 | — | — | EP | disclosed |
| US-4303765-A | PEPTIZATION WITH AROMATIC POLYSULFIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-12-01 | — | — | US | disclosed |
| EP-0022634-A1 | Acylated indole derivatives, processes for their preparation and pharmaceutical compositions and drugs comprising them | TEIJIN LIMITED (JP) | 1981-01-21 | — | — | EP | disclosed |
| US-3937718-A | CARBOXYLIC ACIDS, ALCOHOLS, TERTIERY PHOSPHINES, DISULFIDES, SULFENIC ACID ESTER | SANKYO COMPANY LIMITED (JA) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760864-B2 | Trisulfide compound | TST, TMT1A, SULT1A1 | APOBEC3G 2686/4885EHMT2 1740/4885EHMT1 1571/4885 |
| US-12091425-B2 | Compounds that inhibit MCL-1 protein | MCL1, BCL9, BCL2L1 | APOBEC3G 3534/4885EHMT2 3337/4885EHMT1 2231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.